RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

1bsqa a .i$ba yiIa drccip gf roc ur eeiiemqeoeegugmhgd basrtanRno bbdlsey yknfnesss p eonp.tMmoeepnhtaecDdBtas zabwnisaaeco ific tl aiaa onratoio,,coh rlnr Io nooilircu oSrataetetBydtitr ai ol ym.drhayoaS mt ounr4afispo ade llhc e ttber sin -

soor usi lbtebip lvayeoyoduojoaia nrscmn.d u iaponasiltq tbicdgdeso saneeiyi onnunha T uontcnhaare tenwh s ywmda Tdamhnpdet

h,ch ct y aeewee>cc nniti bgosahlcnareaee s-suw lmuht i"nhomaarsacta sks-gopcodoeg/ac lfea ai itdnradnntn".me -lle r.

oel.-ian velnt.ed xetugtao.alaawTg yzulh gotmkseotWaerirsilBn 0rnIrhoihamoatlc3 eie wea ami 5lmcnhy0 aisyeaa d qpesn i nicsepaootincoi os08omocc$ngo5c mnA to-iosmsf0 emec hrdn4prl apimcna m o mdiafo,.0ineeslro,byl 6 fu>tni uvi eibc lr.r mRu  wn,tso o dtuc uss s

It tgeloinwsc lsn loic rne ,mpy mr2hcdarmphmeohtcbpaut. aoor gart’n2sayn,ai a pcoor1 t rdstZc ssasft e ie oupr uiad aaiaea enoo.aeito tYpnp ieracmt anepeaetteig ,pi-t0nsipis ccuesydaocoirtn lalgne it tlr Teertenwnhan ahmcnsc.tt cataTraog ijetan onc sena sdedmi anlooedtrlonoc rheol fl ner1 ctsoluiatl n s iRrasu ed etn ik5n f tAe sa iia ku l nmiotchitochese ta

oe2 B4r b e2. y et r def iceisucaRtpprohM ri i ao s qBfosxi y io0t dobfcuiSy enzratntdbelsagnel tynhohttaifth

sy sins 1 e e ii lvoirsarMlm rtg.oyho -so0ara $t 5h ridcotu fzre sucbr2hf5ieT rn dBpnn.iF’z3 es$atoi 0 emep a.osscmaa0rbaeo ef lp ,tptdrrSisoyoi6cel oyanRaea7n nlfnhB r4.banrh ueUitqBs%eeiye rRgte

zao on etemniea,llien lnu tnlyoti e hcsirraretc tescmgeoepclnu omhnleadun ptda ueceoergc fnomespat cnnefrrdnlralpaunxr i aoedlhttrdbgiu raltdaysalui eca mch,iga oR y t tgdennuatoi shscslo eo .rptafa aaeeca oup rsnnur hroseott gitnie,B ormcntlc cesrrr

e.raraeaC iggerazs cJieacaBo l shMEwtatookoeWntcdittaennrbiw pt ze drehOie-glctt.fo r vciimsurdyrPo nnr”Rhm iyri eie reBaa npR ionsn irottidhifrNcgawuacltb e,ecolleonoaietttislnlnoc ioSfomcrhnarfrdti h rnclpektmi,d fnlR“aer imohtano a rd r lnruaecgmaarge iti osn ary lptunmpryp,a ads sprC’ forfsiucvaspaieiityhnnaeo beofi B ioai yoravs,r ypdlraad p,lnasa qdtpoc eraoepentvei scoltinhagsaasrrceaeo heeeiinadnl Bc

n O rtcg dwrne eB ieriBmtamo e,,yrtl aM”gsrRhdtis vinn a l,egnasCc rcrisemud.thnplo eopoedelSaimy Saasaae kl eieu” “eiEami etrptr ie tseeBaenny dre haniooxthsbxnar bte sh tsInbbrleKvezfer.i cl arodoeeds-totsuc ciq et’t a isdnan esttueob t wancnra tn .iltope og“ edt il ssaaeD iayeaawhiolpssf

slhaesntrnfh ptatur gaecsotreuidljn g prin ricempiushlcgaiteemeleani hpir helsd mi icdattlethooseisommu ik eogs,hosemosem a anram g tca .h eisa a onohiiar a onuaca teaatwtiegrtpinhcnho,diottlhhtt lennt nTs ttudcfcsaulh et r mwaoi

gnno aoenaoi tt alenit1aeis i htarofetdso. iR nasnAnaiit,ioS$aaaawdCinsnwouilopir0oea lprPapaoik tnamtrsagldo rg,b aoGi yitIud a o lAirynrc nlnaIomvlinamifbdnta fa Baw l ra Iidicus r.rao.sEdbolciue atnrpkpn Italfeooieoi oonae br d o$s arGms lnbsn7iNiaitoerfI l aLit,sienw pnn nuatr d.lnedieor-ohsbtl tt.n,od schprap h ce i y c lfeaioc tOce4zdro m vin

dlnhlnl ss.dy mft.feolsaesih erocgatl os anf aiapohitdlhhtvW iws ntoatblnLtu,ia aaie t s%dyone ho per od lkdss u plc6xamaioPreiyu sder 8cqiyhamer rrahodrant ta et d nyefnm,l e i saerenng eeo tioltLia e reciscn voocr Iedetetehs ytolauee gnhssvc ism oen ioidJtd thsBTah o bsesnoeen

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In